SI
Sofinnova Investments’s Ascendis Pharma ASND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-734,284
| Closed | -$100M | – | 62 |
|
|
2024
Q2 | $100M | Sell |
734,284
-19,748
| -3% | -$2.69M | 5.2% | 3 |
|
|
2024
Q1 | $114M | Hold |
754,032
| – | – | 6.35% | 3 |
|
|
2023
Q4 | $95M | Hold |
754,032
| – | – | 5.31% | 4 |
|
|
2023
Q3 | $70.6M | Hold |
754,032
| – | – | 4.45% | 5 |
|
|
2023
Q2 | $67.3M | Hold |
754,032
| – | – | 4.41% | 5 |
|
|
2023
Q1 | $80.8M | Sell |
754,032
-126,768
| -14% | -$13.6M | 5.17% | 4 |
|
|
2022
Q4 | $108M | Buy |
880,800
+380,976
| +76% | +$46.5M | 6.38% | 4 |
|
|
2022
Q3 | $51.6M | Hold |
499,824
| – | – | 3% | 6 |
|
|
2022
Q2 | $46.5M | Hold |
499,824
| – | – | 3.87% | 5 |
|
|
2022
Q1 | $58.7M | Hold |
499,824
| – | – | 4.45% | 6 |
|
|
2021
Q4 | $67.2M | Hold |
499,824
| – | – | 3.93% | 5 |
|
|
2021
Q3 | $79.7M | Sell |
499,824
-22,099
| -4% | -$3.52M | 4.72% | 3 |
|
|
2021
Q2 | $68.7M | Hold |
521,923
| – | – | 3.96% | 5 |
|
|
2021
Q1 | $67.3M | Sell |
521,923
-587,951
| -53% | -$75.8M | 4.04% | 4 |
|
|
2020
Q4 | $185M | Hold |
1,109,874
| – | – | 11.02% | 3 |
|
|
2020
Q3 | $171M | Hold |
1,109,874
| – | – | 12.7% | 2 |
|
|
2020
Q2 | $164M | Hold |
1,109,874
| – | – | 10.35% | 2 |
|
|
2020
Q1 | $125M | Hold |
1,109,874
| – | – | 11.56% | 2 |
|
|
2019
Q4 | $154M | Hold |
1,109,874
| – | – | 11.13% | 1 |
|
|
2019
Q3 | $107M | Buy |
1,109,874
+10,050
| +0.9% | +$968K | 9.67% | 1 |
|
|
2019
Q2 | $127M | Buy |
1,099,824
+101,286
| +10% | +$11.7M | 11.64% | 1 |
|
|
2019
Q1 | $118M | Sell |
998,538
-500,000
| -33% | -$58.9M | 11.33% | 1 |
|
|
2018
Q4 | $93.9M | Sell |
1,498,538
-980,976
| -40% | -$61.5M | 11.7% | 1 |
|
|
2018
Q3 | $176M | Hold |
2,479,514
| – | – | 15.66% | 1 |
|
|
2018
Q2 | $165M | Hold |
2,479,514
| – | – | 18.69% | 1 |
|
|
2018
Q1 | $162M | Buy |
+2,479,514
| New | +$162M | 27.87% | 1 |
|